Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial

January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p145
Academic Journal
The article presents a research which examines the comparative efficacy of olanzapine, quetiapine, risperidone, and ziprasidone as anti-depressive drugs. It is reported that, the researchers used several methods including, Calgary Depression Scale for Schizophrenia (CDSS) for conducting the research. According to the research, there exists no substantial differences in the comparative efficacy of the drugs.


Related Articles

  • Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey. Kalsekar, Iftekhar; Wagner, Jan-Samuel; DiBonaventura, Marco; Bates, Jay; Forbes, Robert; Hebden, Tony // Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p81 

    Background: Use of atypical antipsychotics (AA) in combination with an antidepressant is recommended as an augmentation strategy for patients with depression. However, there is a paucity of data comparing aripiprazole and other AAs in terms of patient reported outcomes. Therefore, the objective...

  • Independent Nurse: Journals Watch - Newer antipsychotics do not reduce the risk of falls.  // GP: General Practitioner;9/16/2005, p73 

    The article reports that American researchers monitored over 2,000 patients and found the increased risk of falls associated with typical antipsychotics was 35 percent compared with 32 percent for risperidone and 74 percent for olanzapine. Those taking antidepressants were at a 45 percent...

  • Risperidone/ziprasidone.  // Reactions Weekly;7/21/2012, Issue 1411, p39 

    The article presents a case study of a 26-year-old female patient who developed worsening spasticity while receiving risperidone and ziprasidone.

  • Olanzapine/ziprasidone.  // Reactions Weekly;6/18/2011, Issue 1356, p27 

    The article describes the case of a 51-year-old woman with a severe depressive episode who gained weight during treatment with olanzapine and developed pruritus while taking ziprasidone.

  • Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Ou, Jian-Jun; Xu, Yi; Chen, Hong-Hui; Fan, Xiaoduo; Gao, Keming; Wang, Juan; Guo, Xiao-Feng; Wu, Ren-Rong; Zhao, Jing-Ping // Psychopharmacology;Feb2013, Vol. 225 Issue 3, p627 

    Objective: The objective of the study was to compare metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Methods: In this 6-week, multicenter, open-label trial, 260 patients were randomly assigned to receive ziprasidone or olanzapine...

  • The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study. Lee, Hwang-Bin; Yoon, Bo-Hyun; Kwon, Young-Joon; Woo, Young; Lee, Jung-Goo; Kim, Moon-Doo; Bahk, Won-Myong // Clinical Drug Investigation;Oct2013, Vol. 33 Issue 10, p743 

    Background: Switching antipsychotic medication in patients undergoing combination therapy for bipolar I disorder is a common clinical practice because of suboptimal drug efficacy or tolerability. Despite the frequency of switching, little is known about the most appropriate switching options....

  • Cochrane Briefs. KRIPKE, CLARISSA // American Family Physician;2/1/2011, Vol. 83 Issue 3, p260 

    The article explores the effects of clozapine (Clozaril) in patients with schizophrenia and schizophrenia-like psychoses based on trials. Studies have revealed that clozapine is more effective than risperidone although they have also found that clozapine have more adverse effects than...

  • Treatment options of delusional parasitosis: case series of 14 patients. COŞAR, Behçet; TAŞKINOĞLU, Kardem; LEPPING, Peter; BURHANOĞLU, Sabri; YAPICI ESER, Hale; TANER, Mustafa Ender; ARIKAN, Zehra // Anatolian Journal of Psychiatry / Anadolu Psikiyatri Dergisi;Sep2012, Vol. 13 Issue 3, p239 

    Objective: Delusional parasitosis (DP) is a rare psychiatric disorder in which patients develop the delusional belief that they are infested by parasites. Second generation antipsychotics and antidepressants can be used for its treatment. Traditionally the first generation antipsychotic pimozide...

  • Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics. Grover, Sandeep; Dutt, Alakananda; Chakrabarty, Kaustav; Kumar, Vineet // Industrial Psychiatry Journal;Jan-Jun2012, Vol. 21 Issue 1, p69 

    Non-catatonic mutism in schizophrenia has been described less frequently in literature. We describe the case of a young male who presented with non-catatonic mutism, secondary to fi rst rank symptoms, which was refractory to adequate antipsychotic trials (quetiapine, risperidone, aripiprazole,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics